Compare drug alternatives
Sajazir® Alternatives
Sajazir®(Icatibant) | Takhzyro®(Lanadelumab-Flyo) |
|---|---|
Prescription Only | Prescription Only |
| Dosage & Administration | Dosage & Administration comparison data |
Administration | |
Subcutaneous. Learn more. | |
Dosing | |
30 mg injected subcutaneously in the abdominal area. If response is inadequate or symptoms recur, additional injections of 30 mg may be administered at intervals of at least 6 hours. . Learn more. | |
Latin Shorthand | |
30 mg SC (subcutaneous) in abdomen. If inadequate response or recurring symptoms, administer additional 30 mg injections at ≥6-hour intervals.. Learn more. | |
| Financial Assistance | Financial Assistance comparison data |
Out-Of-Pocket Costs With Copay Card | |
Annual Cap | |
Assistance Expiration | |
Generics | |
No lower-cost generic available | No lower-cost generic available |
| Physician Advisory | Physician Advisory comparison data |
Adverse Reactions | |
The most commonly reported adverse reactions were injection site reactions,
which occurred in almost all patients (97%) in clinical trials. Other common
adverse reactions occurring in greater than 1% of patients included pyrexia,
transaminase increase, dizziness, and rash. . Learn more. | The most common adverse reactions (≥10%) are injection site
reactions, upper respiratory infections, headache, rash, dizziness,
diarrhea, and myalgia.. Learn more. |
Mechanism of Actions (MoA) | |
Drugs used in Hereditary Angioedema. Learn more. | |
Special Populations | |